Your Article Summary
See Latest ArticlesDeterminants of recovery from amenorrhea in premenopausal breast cancer patients receiving adjuvant chemotherapy in the taxane era
Anti-Cancer Drugs, 07/02/09
Minisini AM et al. - In a trial to retrospectively analyze the incidence of amenorrhea after adjuvant chemotherapy and subsequent recovery of menses in 145 breast cancer pts, it was determined that recovery of menses after chemotherapy-induced amenorrhea occurs more probably in younger women, with no pregnancies and receiving taxanes.
Methods- Incidence of amenorrhea after adjuvant chemotherapy and subsequent recovery of menses were analyzed in 145 breast cancer pts.
- Age, smoking, alcohol consumption, body mass index, chemotherapy regimen, previous hormonal therapies, and previous childbearing were analyzed as potential predictive factors of ovarian function recovery.
- Median age was 42 yrs at the beginning of adjuvant chemotherapy with 30.3% of pts below 40 yrs of age.
- The majority (87.6%) of pts received anthracycline-based chemotherapy, 35.2% of pts received a cyclophosphamide-methotrexate-5-fluorouracil regimen, and 42.8% received a taxane.
- Incidence of chemotherapy-induced amenorrhea was 80, and 35.3% of these pts resumed menses after a median of 8 mos.
- Younger age (<40 yrs) and taxane-based chemotherapy were associated with increased probability of recovery of menses after chemotherapy-induced amenorrhea.
- Cyclophosphamide-methotrexate-5-fluorouracil-based chemotherapy and previous childbearing were associated with an increased probability of permanent chemotherapy-induced amenorrhea.
Related Articles
Assessment of Myocardial Ischemic Memory Using Persistence of Post-Systolic Thickening After Recovery From Ischemia
JACC - Journal of the American College of Cardiology: Cardiovascular Imaging, 11/16/09
Relevance Score: 66%
Muscle and bone follow similar temporal patterns of recovery from muscle-induced disuse due to botulinum toxin injection
Bone, 11/12/09
Relevance Score: 66%
Delayed cerebral thrombosis after initial good recovery from pneumococcal meningitis
Neurology, 11/06/09
Relevance Score: 66%
Effects of maintaining a remifentanil infusion on the recovery profiles during emergence from anaesthesia and tracheal extubation
British Journal of Anesthesia, 11/02/09
Relevance Score: 66%
Evaluation of automated and manual commercial DNA extraction methods for the recovery of Brucella spp. DNA from suspensions and spiked swabs
Journal of Clinical Microbiology, 10/23/09
Relevance Score: 66%
Today in Breast...keeping you current
Receive free subspecialty "5-minute updates" via email
The risk for breast cancer is not evidently increased in women with hyperprolactinemia
Pituitary, 12/20/09
Extracellular Signal–Regulated Kinase Signaling Pathway Regulates Breast Cancer Cell Migration by Maintaining slug Expression
Cancer Research, 12/20/09
Invasion of Human Breast Cancer Cells In vivo Requires Both Paracrine and Autocrine Loops Involving the Colony-Stimulating Factor-1 Receptor
Cancer Research, 12/19/09
Today in Gynecologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy
BMC Cancer, 12/20/09
Epithelial-to-Mesenchymal Transition and Ovarian Tumor Progression Induced by Tissue Transglutaminase
Cancer Research, 12/20/09
Adult-Type Granulosa Cell Tumors and FOXL2 Mutation
Cancer Research, 12/20/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Nilotinib As Front-Line Treatment for Patients With Chronic Myeloid Leukemia in Early Chronic Phase
Journal of Clinical Oncology, 12/20/09
Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance
Journal of Clinical Oncology, 12/20/09
Safety and Efficacy of Romiplostim in Patients With Lower-Risk Myelodysplastic Syndrome and Thrombocytopenia
Journal of Clinical Oncology, 12/20/09